GansAVerrengiaEPRicchiutiE, et al. Ocrelizumab-associated cryptogenic organising pneumonia in multiple sclerosis: Two case reports and comprehensive literature review. Mult Scler J2024; 31(6): 740–743.
2.
AysanNKöybaşıGSatıcıC, et al. Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report. Tuberk Toraks2023; 71(1): 107–111.
3.
LiotéHLiotéFSéroussiB, et al. Rituximab-induced lung disease: A systematic literature review. Eur Respir J2010; 35: 681–687.
4.
KingTELeeJS. Cryptogenic organizing pneumonia. N Engl J Med2022; 386: 1058–1069.
5.
BaberUBouleyAEgnorE, et al. Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients. J Neurol2018; 265(10): 2342–2345.
